Home › Funds › Invenomic Capital Management LP › UHS

Invenomic Capital Management LP position in UHS

UNIVERSAL HLTH SVCS INC · Health Care

Invenomic Capital Management LP reported holding 427,264 shares of UHS (UNIVERSAL HLTH SVCS INC) in its Q2 2026 13F filing — a position valued at US$63.5M, representing 3.79% of its reported portfolio and ranking #2 among its reported holdings. Invenomic Capital Management LP has disclosed UHS holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)427.26K sh
Reported value held$63.53M
Portfolio Weight3.79%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's UHS position evolved

Invenomic Capital Management LP first disclosed a stake in UHS in Q3 2023 at 119,174 shares (US$15.0M). The position peaked in Q2 2026 at 427,264 shares, worth US$63.5M. Across 6 filings, Invenomic Capital Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 427,264 shares valued at US$63.5M — an increase of 242,155 shares quarter over quarter.. Notable position changes include a 63% trim in Q4 2023 (shares rose 20% over the following quarter), a 174% increase in Q3 2025 (shares rose 7% over the following quarter), a 131% increase in Q2 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 119.17K $14.98M New
Q4 2023 44.52K $6.79M Reduce
Q2 2025 26.73K $4.84M New
Q3 2025 73.27K $14.98M Add
Q1 2026 185.11K $33.13M New
Q2 2026 427.26K $63.53M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UHS and 13F data

UHS (UNIVERSAL HLTH SVCS INC) is a Health Care company. 19 other funds we track also report a position in UHS — the largest reported positions include First Eagle Investment Management (US$677.2M), Pzena Investment Management (US$292.8M), LOS ANGELES CAPITAL MANAGEMENT LLC (US$158.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UHS

All UHS fund holders →

FAQ

How long has Invenomic Capital Management LP held UHS?

Invenomic Capital Management LP has disclosed UHS holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is Invenomic Capital Management LP's current position in UHS?

As of Q2 2026, Invenomic Capital Management LP holds 427.26K shares of UHS (UNIVERSAL HLTH SVCS INC), valued at $63.53M, representing 3.79% of its reported portfolio and ranking #2.

Has Invenomic Capital Management LP been buying or selling UHS?

In the latest 13F filing (Q2 2026), Invenomic Capital Management LP increased its position in UHS. The position peaked in Q2 2026 at 427.26K shares.

Which other funds hold UHS?

Other major institutional holders of UHS include First Eagle Investment Management, Pzena Investment Management, LOS ANGELES CAPITAL MANAGEMENT LLC, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.